Skip to product information
1 of 1

MDPI AG

Biofilm-Based Nosocomial Infections

Biofilm-Based Nosocomial Infections

Regular price $41.00 USD
Regular price Sale price $41.00 USD
Sale Sold out
Shipping calculated at checkout.
Quantity

The well-known persistence in the nosocomial environment of multidrug resistant bacterial

and fungal species, today responsible for a wide variety of healthcare-associated infections, is

believed to be greatly promoted by the ability of most of them to adhere and to grow in sessile

mode on mucosal and soft tissues of hospitalized patients, as well as on the inner and outer

surfaces of indwelling medical devices, including intravenous catheters, orthopaedic, cardiac

valves, intrauterine devices, and contact lenses.

In this regard, a large number of these microorganisms, such as Acinetobacter baumannii,

Candida albicans, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and

Staphylococcus aureus, give rise to highly organized, sessile community defined biofilms, in

which microbes grow encased in a hydrated matrix of extracellular polymeric substances

produced by themselves and are well protected from the attack of antimicrobial molecules and

from the host immune response, by resisting phagocytosis and other body's defense systems.

The great influence of the sessile growth on the effectiveness of the antibiotic therapies is due

to both the structure and function of these microbial communities, making these also 1000

times more tolerant to antibiotics and disinfectants. Thus, alternative approaches to the

common antibiotic treatments are emerging for preventing and treating both the mono-species

and the most frequent multi-species biofilms, including enzymes able to disrupt mature

biofilms and new biomaterials for the coating of medical devices to counteract microbial

adhesion and biofilm formation.

The aim of this Special Issue is to report on the state-of-art of the basic and applied research

in the field of biofilm-based nosocomial infections that can be acquired by patients in both

general hospitals and long-term care settings. Particularly, the involvement of microbial

biofilms in medical device-related infections and other healthcare-associated infections, so far

underestimated and/or scarcely investigated, has been considered, reviewed, and discussed.

View full details